Jury Hits Johnson & Johnson With $8B Verdict In Case Claiming Company Downplayed Risks Of Anti-Psychotic Drug

The plaintiff sued Johnson & Johnson in 2013 saying that he grew breasts — a condition known as gynecomastia — after he began using Risperdal in 2003, at age 9, to treat symptoms of autism. His case is one of more than 10,000 similar suits against the company.

from Kaiser Health News https://ift.tt/2B1XMcd